AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

President-elect Donald Trump announced that Tesla CEO Elon Musk and biotech investor Vivek Ramaswamy will lead a new ...

The research, led by Dr. Daniel Myran, a Canada Research Chair in Social Accountability at the University of Ottawa, followed ...

The clinical-stage biopharmaceutical company said it has enough cash to reach the milestones it laid out for 2025.

with some evidence pointing to psychedelic mushrooms’ positive impact on some people with depression, anxiety and substance ...

In blue and red states, voters rejected these industry-backed proposals, favoring policies that prioritize public health and ...

Earlier this year, a phase 2a, 167-patient Alzheimer's-related depression trial recruited 167 patients in ... Telix shares ...

Recent research indicates that psychedelics can be effective in treating conditions such as depression, post-traumatic stress ...

If psychedelic therapy using psilocybin, or magic mushrooms, can gain FDA approval, more than 5 million Americans with severe ...

Over the course of a lifetime, as many as seven in 10 adults in the United States will directly experience or witness harrowing events. These include gun violence, car accidents, and other personal ...